A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes
- PMID: 27102181
- PMCID: PMC7094544
- DOI: 10.1016/j.chest.2016.04.009
A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes
Abstract
Background: Nonventilated hospital-acquired pneumonia (NVHAP) is a serious nosocomial infection that is increasingly attributed to antibiotic-resistant bacteria.
Methods: This is a retrospective case-control study comparing patients with and those without NVHAP from January 1, 2014 to December 31, 2014 at Barnes-Jewish Hospital, a 1,300-bed urban academic medical center in St. Louis, Missouri.
Results: One hundred seventy-four consecutive patients with NVHAP were enrolled. A random sample of 696 control patients matched by age, sex, race, and hospital admission date were selected from a total of 5,322 potential matched control subjects. NVHAP was pathogen-negative in 98 cases (56.3%). Respiratory viruses were identified in 42 patients (24.1%), gram-negative bacteria were seen in 25 patients (14.4%), and gram-positive bacteria were identified in 20 patients (11.5%). Individuals in whom NVHAP developed were more likely to die (15.5% vs 1.6%; P < .01), to require intensive care (56.3% vs 22.8%; P < .01) or mechanical ventilation (19.0% vs 3.9%; P < 0.01), and to have a longer hospital length of stay (15.9 days [range, 9.8-26.3 days] vs 4.4 days [range, 2.9-7.3 days]; P < 0.01). This case-control study identified a strong association between hospital mortality and NVHAP, with patients who acquired NVHAP having an 8.4 times greater odds of death (95% CI, 5.6-12.5).
Conclusions: The occurrence of NVHAP was associated with significant increases in mortality, the use of intensive care and mechanical ventilation, and hospital length of stay. We also found that respiratory viruses were an important cause of NVHAP. These findings suggest that efforts aimed at the successful prevention of NVHAP could improve patient outcomes and reduce health-care costs.
Keywords: antibiotic resistance; outcomes; pneumonia.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Figures


Comment in
-
Going Viral: Importance of Viral Pathogens in Nonventilated Hospital-Acquired Pneumonia.Chest. 2016 Nov;150(5):991-992. doi: 10.1016/j.chest.2016.05.028. Chest. 2016. PMID: 27832891 No abstract available.
References
-
- American Thoracic Society; Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. - PubMed
-
- Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867–903. - PubMed
-
- Vincent J.L., Rello J., Marshall J. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. - PubMed
-
- Denys G.A., Relich R.F. Antibiotic resistance in nosocomial respiratory infections. Clin Lab Med. 2014;34(2):257–270. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical